18 Feb 2025

Kestra Medical Technologies, Ltd. Appoints Al Ford as Chief Commercial Officer

(Kirkland, Washington) – February 18, 2025 – Kestra Medical Technologies Ltd. (“Kestra”), a wearable medical device and digital healthcare company, announced today that Al Ford is joining the company as Chief Commercial Officer (CCO). Mr. Ford will be responsible for advancing sales strategies and leading the Kestra commercial team.

Newsroom

25 Jul 2024

Kestra Medical Technologies Announces Appointment of Veteran Medical Device Executive, Raymond W. Cohen, to its Board of Directors

24 Jul 2024

Kestra Medical Technologies Announces $196 Million Oversubscribed Financing Round

04 Jan 2024

Kestra Medical Technologies Surpasses 200 Million Covered Lives for ASSURE Wearable Cardioverter Defibrillator (WCD) System

22 Sep 2023

Kestra Medical Technologies Offers Electrophysiology and Cardiology Clinicians Opportunity to Wear ASSURE WCD System at #HRX2023 Conference

29 Nov 2022

Kestra Medical Technologies Surpasses 100 Million Covered Lives for ASSURE Wearable Cardioverter Defibrillator (WCD) System

11 Apr 2022

ASSURE Wearable Cardioverter Defibrillator (WCD) System Earns 2022 Medical Design Excellence Award

01 Apr 2022

ASSURE Wearable Cardioverter Defibrillator (WCD) System Demonstrates Low False Alarm Rates, High Patient Compliance in Clinical Study

03 Aug 2021

Kestra Medical Technologies Receives FDA Approval for ASSURE Wearable Cardioverter Defibrillator (WCD)

Have Questions?

We’re here to help.

ASSURE System

Support

About Kestra

Questions?